(1 - 7 von 7
)
Lilly To Release Early-Stage Pipeline Data Targeting Key Cancer...
investor.lilly.com
... and dimer with activity against BRaf or Ras mutant tumor cells and minimal paradoxical activation; Author/Speaker: Sheng-Bin Peng , Ph.D.
sortiert nach Relevanz / Datum